IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 265 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.49 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $154 | -100.0% | 21,851 | -48.6% | 0.01% | -87.4% |
Q1 2021 | $1,345,000 | +345.4% | 42,480 | +553.6% | 0.10% | +187.9% |
Q4 2020 | $302,000 | -51.0% | 6,499 | -65.3% | 0.03% | -68.9% |
Q3 2020 | $616,000 | +13.2% | 18,711 | -5.6% | 0.11% | +68.3% |
Q2 2020 | $544,000 | +153.0% | 19,831 | +67.9% | 0.06% | +270.6% |
Q3 2019 | $215,000 | +117.2% | 11,814 | +13.8% | 0.02% | +183.3% |
Q1 2019 | $99,000 | -85.5% | 10,385 | -82.9% | 0.01% | -85.7% |
Q3 2018 | $684,000 | +273.8% | 60,812 | +166.0% | 0.04% | +320.0% |
Q4 2017 | $183,000 | – | 22,861 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |